• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

7-(4-甲氧基苯基)-4,9-二甲基-N-(4-甲基苯基)-5,12-二氮杂四苯-6-胺

7-(4-Meth-oxy-phen-yl)-4,9-dimethyl-N-(4-methyl-phen-yl)-5,12-diaza-tetra-phen-6-amine.

作者信息

Vennila K N, Prabha K, Prasad K J Rajendra, Velmurugan D

出版信息

Acta Crystallogr Sect E Struct Rep Online. 2011 Apr 1;67(Pt 4):o762-3. doi: 10.1107/S1600536811006209. Epub 2011 Mar 2.

DOI:10.1107/S1600536811006209
PMID:21754058
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3099846/
Abstract

In the title compound, C(32)H(27)N(3)O, the fused tetra-cycilc ring system is essentially planar [r.m.s. deviation = 0.07 (7) Å]. An intra-molecular N-H⋯π(arene) inter-action and a weak intra-molecular C-H⋯N hydrogen bond may influence the mol-ecular conformation. In the crystal, weak inter-molecular C-H⋯N hydrogen bonds link the mol-ecules into centrosymmetric dimers, forming R(2) (2)(14) motifs. In addition, weak π-π stacking inter-actions with centroid-centroid distances in the range 3.578 (1)-3.739 (1) Å provide further stabilization.

摘要

在标题化合物C(32)H(27)N(3)O中,稠合四环体系基本呈平面状[r.m.s.偏差 = 0.07 (7) Å]。分子内N-H⋯π(芳烃)相互作用和弱分子内C-H⋯N氢键可能影响分子构象。在晶体中,弱分子间C-H⋯N氢键将分子连接成中心对称二聚体,形成R(2) (2)(14) motif。此外,质心间距在3.578 (1)-3.739 (1) Å范围内的弱π-π堆积相互作用提供了进一步的稳定性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66b/3099846/6f9b0d56bc17/e-67-0o762-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66b/3099846/effb7056d952/e-67-0o762-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66b/3099846/6f9b0d56bc17/e-67-0o762-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66b/3099846/effb7056d952/e-67-0o762-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b66b/3099846/6f9b0d56bc17/e-67-0o762-fig2.jpg

相似文献

1
7-(4-Meth-oxy-phen-yl)-4,9-dimethyl-N-(4-methyl-phen-yl)-5,12-diaza-tetra-phen-6-amine.7-(4-甲氧基苯基)-4,9-二甲基-N-(4-甲基苯基)-5,12-二氮杂四苯-6-胺
Acta Crystallogr Sect E Struct Rep Online. 2011 Apr 1;67(Pt 4):o762-3. doi: 10.1107/S1600536811006209. Epub 2011 Mar 2.
2
2,9-Dimethyl-7-phenyl-N-(4-methyl-phen-yl)dibenzo[b,h][1,6]naphthyridin-6-amine.2,9-二甲基-7-苯基-N-(4-甲基苯基)二苯并[b,h][1,6]萘啶-6-胺
Acta Crystallogr Sect E Struct Rep Online. 2010 Dec 11;67(Pt 1):o102-3. doi: 10.1107/S1600536810051196.
3
5-[(4-Fluoro-anilino)meth-yl]-6-methyl-N-(4-methyl-phen-yl)-2-phenyl-pyrimidin-4-amine.5-[(4-氟苯胺基)甲基]-6-甲基-N-(4-甲基苯基)-2-苯基嘧啶-4-胺
Acta Crystallogr Sect E Struct Rep Online. 2012 Oct 1;68(Pt 10):o2922. doi: 10.1107/S160053681203783X. Epub 2012 Sep 12.
4
4-{2-[2-(4-Chloro-benzyl-idene)hydrazinyl-idene]-3,6-dihydro-2H-1,3,4-thia-diazin-5-yl}-3-(4-meth-oxy-phen-yl)sydnone.4-{2-[2-(4-氯-亚苄基)肼基-亚苄基]-3,6-二氢-2H-1,3,4-噻二嗪-5-基}-3-(4-甲氧基-苯基)西多酮。
Acta Crystallogr Sect E Struct Rep Online. 2011 May 1;67(Pt 5):o1175-6. doi: 10.1107/S1600536811013900. Epub 2011 Apr 22.
5
1-(4-Meth-oxy-phen-yl)-4-(4-methyl-phen-yl)-3-phen-oxy-azetidin-2-one.1-(4-甲氧基苯基)-4-(4-甲基苯基)-3-苯氧基氮杂环丁烷-2-酮
Acta Crystallogr Sect E Struct Rep Online. 2011 Jan 12;67(Pt 2):o326-7. doi: 10.1107/S1600536811000663.
6
5-[(3,5-Dichloro-anilino)meth-yl]-N-(3,5-dichloro-phen-yl)-6-methyl-2-phenyl-pyrimidin-4-amine.5-[(3,5-二氯苯胺基)甲基]-N-(3,5-二氯苯基)-6-甲基-2-苯基嘧啶-4-胺
Acta Crystallogr Sect E Struct Rep Online. 2012 Dec 1;68(Pt 12):o3412. doi: 10.1107/S160053681204665X. Epub 2012 Nov 24.
7
tert-Butyl N-{4-methyl-3-[4-(3-pyrid-yl)pyrimidin-2-yl-oxy]phen-yl}carbamate.N-{4-甲基-3-[4-(3-吡啶基)嘧啶-2-基氧基]苯基}氨基甲酸叔丁酯
Acta Crystallogr Sect E Struct Rep Online. 2009 Jul 11;65(Pt 8):o1849. doi: 10.1107/S1600536809025604.
8
Methyl 11-hy-droxy-9-[1-(4-meth-oxy-phen-yl)-4-oxo-3-phen-oxy-azetidin-2-yl]-18-oxo-10-oxa-2-aza-penta-cyclo-[9.7.0.0(1,8).0(2,6).0(12,17)]octa-deca-12(17),13,15-triene-8-carboxyl-ate.11-羟基-9-[1-(4-甲氧基苯基)-4-氧代-3-苯氧基氮杂环丁烷-2-基]-18-氧代-10-氧杂-2-氮杂五环-[9.7.0.0(1,8).0(2,6).0(12,17)]十八碳-12(17),13,15-三烯-8-羧酸甲酯
Acta Crystallogr Sect E Struct Rep Online. 2012 Jul 1;68(Pt 7):o2200-1. doi: 10.1107/S1600536812027341. Epub 2012 Jun 23.
9
(E)-Methyl 3-(3,4-dimeth-oxy-phen-yl)-2-[(1,3-dioxoisoindolin-2-yl)meth-yl]acrylate.(E)-3-(3,4-二甲氧基苯基)-2- [(1,3-二氧代异吲哚啉-2-基)甲基]丙烯酸甲酯
Acta Crystallogr Sect E Struct Rep Online. 2012 Apr 1;68(Pt 4):o1107. doi: 10.1107/S1600536812010975. Epub 2012 Mar 17.
10
8-Methyl-2-[4-(trifluoro-meth-yl)phen-yl]-8H-pyrazolo-[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine methanol disolvate.8-甲基-2-[4-(三氟甲基)苯基]-8H-吡唑并[4,3-e][1,2,4]三唑并[1,5-c]嘧啶-5-胺甲醇溶剂合物
Acta Crystallogr Sect E Struct Rep Online. 2010 Jun 26;66(Pt 7):o1835-6. doi: 10.1107/S1600536810024591.

本文引用的文献

1
7-(2-Chloro-phen-yl)-2,6,9-trimethyl-dibenzo[b,h][1,6]naphthyridine.7-(2-氯苯基)-2,6,9-三甲基-二苯并[b,h][1,6]萘啶
Acta Crystallogr Sect E Struct Rep Online. 2010 Aug 28;66(Pt 9):o2426-7. doi: 10.1107/S1600536810030576.
2
3,6-Dimethyl-1-phenyl-4-(2-thien-yl)-8-(2-thienylmethyl-ene)-5,6,7,8-tetra-hydro-1H-pyrazolo[3,4-b][1,6]naphthyridine.3,6-二甲基-1-苯基-4-(2-噻吩基)-8-(2-噻吩基亚甲基)-5,6,7,8-四氢-1H-吡唑并[3,4-b][1,6]萘啶
Acta Crystallogr Sect E Struct Rep Online. 2009 Apr 25;65(Pt 5):o1109-10. doi: 10.1107/S1600536809014810.
3
1,3-Diphenyl-3,4-dihydro-benzo[b][1,6]naphthyridine.
1,3-二苯基-3,4-二氢-苯并[b][1,6]萘啶
Acta Crystallogr Sect E Struct Rep Online. 2010 Apr 17;66(Pt 5):o1114. doi: 10.1107/S1600536810013619.
4
2,9-Dimethyl-7-phenyl-N-(4-methyl-phen-yl)dibenzo[b,h][1,6]naphthyridin-6-amine.2,9-二甲基-7-苯基-N-(4-甲基苯基)二苯并[b,h][1,6]萘啶-6-胺
Acta Crystallogr Sect E Struct Rep Online. 2010 Dec 11;67(Pt 1):o102-3. doi: 10.1107/S1600536810051196.
5
The identification of 8,9-dimethoxy-5-(2-aminoalkoxy-pyridin-3-yl)-benzo[c][2,7]naphthyridin-4-ylamines as potent inhibitors of 3-phosphoinositide-dependent kinase-1 (PDK-1).鉴定 8,9-二甲氧基-5-(2-氨氧基-吡啶-3-基)-苯并[c][2,7]萘啶-4-基胺作为 3-磷酸肌醇依赖性激酶-1(PDK-1)的有效抑制剂。
Eur J Med Chem. 2010 Apr;45(4):1379-86. doi: 10.1016/j.ejmech.2009.12.036. Epub 2009 Dec 28.
6
Benzo[c][2,7]naphthyridines as inhibitors of PDK-1.苯并[c][2,7]萘啶作为丙酮酸脱氢酶激酶-1(PDK-1)的抑制剂
Bioorg Med Chem Lett. 2009 Sep 1;19(17):5225-8. doi: 10.1016/j.bmcl.2009.07.007. Epub 2009 Jul 8.
7
Structure validation in chemical crystallography.化学晶体学中的结构验证
Acta Crystallogr D Biol Crystallogr. 2009 Feb;65(Pt 2):148-55. doi: 10.1107/S090744490804362X. Epub 2009 Jan 20.
8
A short history of SHELX.SHELX简史。
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22. doi: 10.1107/S0108767307043930. Epub 2007 Dec 21.
9
Discovery of dibenzo[c,f][2,7]naphthyridines as potent and selective 3-phosphoinositide-dependent kinase-1 inhibitors.二苯并[c,f][2,7]萘啶作为强效且选择性的3-磷酸肌醇依赖性激酶-1抑制剂的发现。
J Med Chem. 2007 Nov 15;50(23):5547-9. doi: 10.1021/jm070851i. Epub 2007 Oct 17.
10
Antiviral properties of a series of 1,6-naphthyridine and 7, 8-dihydroisoquinoline derivatives exhibiting potent activity against human cytomegalovirus.一系列对人巨细胞病毒表现出强效活性的1,6-萘啶和7,8-二氢异喹啉衍生物的抗病毒特性。
Antimicrob Agents Chemother. 2000 Apr;44(4):929-37. doi: 10.1128/AAC.44.4.929-937.2000.